DNA Sequencing Market (By Product: Instruments, Consumables, and Services; By Technology: Third Generation DNA Sequencing, Next-Generation Sequencing, and Sanger Sequencing; By Application: Clinical Investigation, Oncology, Forensics & Agrigenomics, Reproductive Health, HLA Typing, and Others; By End-Use: Clinical Research, Academic Research, Biotechnology & Pharmaceutical Companies, Hospitals & Clinics, and Others) - Global Market Size, Share, Trends Analysis, Segment Forecast, Regional Outlook 2023 - 2032


The global DNA sequencing market size is expected to be worth around USD 37.99 billion by 2032 from USD 11.06 bn in 2023, with a compound annual growth rate (CAGR) of 14.7% during the forecast period from 2023 to 2032.

DNA Sequencing Market Size 2023 to 2032

To Access our Exclusive Data Intelligence Tool with 15000+ Database, Visit: Precedence Statistics

Key Takeaways

  • North America led the global market with the highest market share in 2022.
  • By Product, the Consumables segment has held the largest market share in 2022.
  • By Technology, the next-generation sequencing segment captured the biggest revenue share in 2022.
  • By Application, the Oncology segment captured the biggest revenue share in 2022.
  • By End-Use, the Academic Research segment is estimated to hold the highest market share in 2022.

DNA Sequencing Market in the U.S. 2023 To 2032

The U.S. DNA sequencing market size was valued at USD 3.79 billion in 2023 and is expected to hit around USD 12.82 billion by 2032, rising at a CAGR of 14.5% from 2023 to 2032.

U.S. DNA Sequencing Market Size 2023 to 2032

North America is Estimated to be the Largest Market for DNA Sequencing

The research report covers key trends and prospects of DNA sequencing products across different geographical regions including North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. Geographically, DNA sequencing market is dominated by North America due to high incidence of cancer and existence of sophisticated healthcare framework. On the other hand, Asia-Pacific is anticipated to witness the rapid growth rate, on account of increasing investment by governments in research and growing awareness regarding precision medicine.

Key market Insights:

The fast development of DNA sequencing technology is providing scientists with the capability to generate information about genetic variation and outlines of gene expression on an unparalleled scale. The DNA sequencing technology is expected to allow scientists in achieving accurate sequencing of whole human genomes within just a few years. This technology will become a routine tool for scientists and clinicians. Numerous sequencing platforms presently in development have the potential to present greater advances in resolution and throughput. The massively parallel sequencing technologies are at present altering almost all fields of genetics, and the field of pharmacogenomics will be no exemption. The most predominant application of the new sequencing technologies in the field of pharmacogenomics is the detection of novel genetic variations that might influence drug response.

Crucial factors accountable for market growth are:

  • Increasing prevalence of cancer
  • Technological advances in next-generation sequencing technologies
  • Rising demand for precision medicine
  • Declining costs of sequencing
  • High investment in research and development

Report Scope of the DNA Sequencing Market

Report Highlights Details
Growth Rate from 2023 to 2032 CAGR of 14.7%
Market Size in 2023 USD 11.06 billion
Market Size by 2032 USD 37.99 billion
Largest Market North America
Fastest Growing Market Asia Pacific
Base Year 2022
Forecast Period 2023 to 2032
Segments Covered Product, technology, Application, End Use
Companies Mentioned Agilent Technologies, Illumina, Inc., QIAGEN, Perkin Elmer, Thermo Fisher Scientific, Hoffmann-La Roche Ltd., Macrogen, Inc., Bio-Rad Laboratories, Inc., Oxford Nanopore Technologies Ltd., Myriad Genetics

 

Significant Market Trends:

Consumables Segment Reported Foremost Market Stake in 2022

Consumables segment recorded the prime market share in the global DNA sequencing market in 2022. Availability of ready-made components for carrying out the process of DNA sequencing is the major reason for high market share of consumables. Other factors such as increasing applications of DNA sequencing are expected to increase the usage of consumables such as kits and reagents over the estimate period.

The Instruments are projected grow at the highest CAGR during the forecast period mainly due to new product launches.

Next-Generation Sequencing is Projected to Dominate the Technology Segment of DNA Sequencing Market Revenue

The application of DNA sequencing in developing diagnostic tests and vaccines for viral diseases such as the SARS CoV-2 has augmented the demand for DNA sequencing exponentially. Thus, high incidence of novel viral diseases and ongoing research and development activity in DNA sequencing are major reason for the high revenue share of next-generation sequencing.

Oncology is Projected to Dominate the Application Segment of DNA Sequencing Market Revenue

Constant research on cancer treatment and increasing demand for precision medicine are the major reasons responsible for the high market share of consumables.

Academic Research Projected to Dominate the End-Use Segment of DNA Sequencing Market Revenue

Factors such as high investment in research and development in the field of DNA sequencing and efforts taken by the governments contribute to the growth of academic research segment.

Top Players contending in the Market:

The companies focusing on research and development are expected to lead the global DNA sequencing market. Leading competitors contending in global DNA sequencing market are as follows:

  • Agilent Technologies
  • Illumina, Inc.
  • QIAGEN
  • Perkin Elmer
  • Thermo Fisher Scientific
  • Hoffmann-La Roche Ltd.
  • Macrogen, Inc.
  • Bio-Rad Laboratories, Inc.
  • Oxford Nanopore Technologies Ltd.
  • Myriad Genetics

In order to better recognize the current status of DNA sequencing, and policies adopted by the foremost countries, Precedence Research predicted the future evolution of the DNA sequencing market. This research study bids qualitative and quantitative insights on DNA sequencing market and assessment of market size and growth trend for potential market segments.

Major Market Segments Covered:

By Product

  • Instruments
  • Consumables
  • Services

By Technology

  • Third Generation DNA Sequencing
  • Next-Generation Sequencing
  • Sanger Sequencing

By Application

  • Clinical Investigation
  • Oncology
  • Forensics & Agrigenomics
  • Reproductive Health
  • HLA Typing
  • Others

By End-Use

  • Clinical Research
  • Academic Research
  • Biotechnology & Pharmaceutical Companies
  • Hospitals & Clinics
  • Others

By Geography

    • North America
      • U.S.
      • Canada
    • Europe
      • Germany
      • France
      • United Kingdom
      • Rest of Europe
    • Asia Pacific
      • China
      • Japan
      • India
      • Southeast Asia
      • Rest of Asia Pacific
    • Latin America
      • Brazil
      • Rest of Latin America
    • Middle East & Africa (MEA)
      • GCC
      • North Africa
      • South Africa
      • Rest of Middle East & Africa

Frequently Asked Questions

What is the current size of the global DNA sequencing market?
The global DNA sequencing market size is expected to be worth around US$ 37.99 billion by 2032 and was valued USD 11.06 billion in 2023.
What is the CAGR of DNA sequencing market?
The global DNA sequencing market is growing at a CAGR of 14.7% over forecast period 2023 to 2032.
How much is the market share of North America DNA sequencing market?
North America dominated the global market with a market share of more than 42%.
What is the CAGR of Asia Pacific region in DNA sequencing market?
Asia Pacific is anticipated to grow at the maximum CAGR of around 14% in the forecast period due to high incidence of viral disorders.
How much was the revenue of next-generation sequencing segment in the DNA sequencing market?
The next-generation sequencing accounted for the largest revenue in the technology segment with more than 52% share in 2022.
Which application segment accounted largest revenue in the DNA sequencing market?
Oncology accounted for the largest revenue in the application segment. High prevalence of cancer in developing regions is the key reason for high market share of oncology.
Which product segment will dominate the overall DNA sequencing market?
Among the product segment, consumables are expected to dominate the overall market.
What is DNA sequencing?
DNA sequencing is a procedure used to ascertain the nucleotide sequence of DNA (deoxyribonucleic acid). The nucleotide sequence is a blueprint that encompasses the directives for building an organism, and no perception of the genetic function or progression can be complete without gaining this data.

PROCEED TO BUY :

   USD 4900
   USD 3800
   USD 2100
   USD 2100
   USD 7500

ASK FOR SAMPLE

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client

Get a Sample